There are 413 resources available
Q&A and discussion
Presenter: To be Announced
Session: Selecting biomarkers to inform neoadjuvant strategies
Resources:
Webcast
188O - EMERALD trial analysis of patient-reported outcomes (PROs) in patients with ER+/HER2_ advanced or metastatic breast cancer (mBC) comparing oral elacestrant vs standard of care (SoC) endocrine therapy
Presenter: Javier Cortes
Session: Proffered Paper session 1
Resources:
Abstract
Slides
Webcast
Invited Discussant 187O and 188O
Presenter: Lisa Carey
Session: Proffered Paper session 1
Resources:
Slides
Webcast
Q&A and discussion
Presenter: To be Announced
Session: Proffered Paper session 1
Resources:
Webcast
Opening session
Presenter: Sung-Bae Kim
Session: Welcome to the ESMO Breast Cancer 2023 and 2023 award lecture
Resources:
Slides
Webcast
Introduction to the ESMO Breast Cancer 2023 award lecture
Presenter: Erika Hamilton
Session: Welcome to the ESMO Breast Cancer 2023 and 2023 award lecture
Resources:
Webcast
Progress through challenging dogma
Presenter: Sara Hurvitz
Session: Welcome to the ESMO Breast Cancer 2023 and 2023 award lecture
Resources:
Slides
Webcast
Welcome and introductions
Presenter: All Speakers
Session: AiCME - Targeted adjuvant strategies for HR-positive HER2-negative early breast cancer: Who can benefit, and how can we optimize their use?
Resources:
Webcast
Assessing risk of recurrence in HR-positive, HER2-negative early breast cancer
Presenter: All Speakers
Session: AiCME - Targeted adjuvant strategies for HR-positive HER2-negative early breast cancer: Who can benefit, and how can we optimize their use?
Resources:
Webcast
Impact of oral targeted adjuvant therapies in patients with HR-positive, HER2-negative early breast cancer
Presenter: All Speakers
Session: AiCME - Targeted adjuvant strategies for HR-positive HER2-negative early breast cancer: Who can benefit, and how can we optimize their use?
Resources:
Webcast